Posted On: 02/01/2013 11:56:27 AM
Post# of 23
Have you read Oncolytics Biotech's (NASDAQ: ONCY) recent press release?
"Oncolytics Biotech® Inc. Announces Positive REOLYSIN® Clinical Trial Data Presented at ASCO Gastrointestinal Cancers Symposium"
http://www.oncolyticsbiotech.com/news_items/d...se_id=1919
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)